240P Efficacy and safety of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in older patients (pts) with HR+/HER2− early breast cancer (EBC) in NATALEE
| Autor: | Untch, M., Yardley, D., Im, S-A., Pluard, T., Hart, L., Crown, J.P., Freyer, G., Zamagni, C., López-Barajas, I. Blancas, Parnizari, F., Gao, M., Amin, K., Hu, H., Rugo, H.S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S313-S314 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|